Cargando…

Inhibition of leukemic cells by valproic acid, an HDAC inhibitor, in xenograft tumors

The chimeric fusion protein, AML1-ETO, generated by translocation of t(8;21), abnormally recruits histone deacetylase (HDAC) to the promoters of AML1 target genes, resulting in transcriptional repression of the target genes and development of t(8;21) acute myeloid leukemia. Abnormal expression of cy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhihua, Hao, Changlai, Wang, Lihong, Liu, Peng, Zhao, Lei, Zhu, Cuimin, Tian, Xia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699303/ https://www.ncbi.nlm.nih.gov/pubmed/23836985 http://dx.doi.org/10.2147/OTT.S46135

Ejemplares similares

GANT61 and Valproic Acid Synergistically Inhibited Multiple Myeloma Cell Proliferation via Hedgehog Signaling Pathway
por: Zhang, Zhihua, et al.
Publicado: (2020)

HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo
por: Segura-Pacheco, Blanca, et al.
Publicado: (2007)

Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19
por: Pitt, Bertram, et al.
Publicado: (2021)

Mechanism of Growth Inhibition of Prostate Cancer Xenografts by Valproic Acid
por: Sidana, Abhinav, et al.
Publicado: (2012)

Valproic acid inhibits tumor angiogenesis in mice transplanted with Kasumi-1 leukemia cells
por: ZHANG, ZHI-HUA, et al.
Publicado: (2014)

Valproic Acid and Other HDAC Inhibitors Upregulate FGF21 Gene Expression and Promote Process Elongation in Glia by Inhibiting HDAC2 and 3
por: Leng, Yan, et al.
Publicado: (2016)

Histone Deacetylases (HDAC) Inhibitor—Valproic Acid Sensitizes Human Melanoma Cells to Dacarbazine and PARP Inhibitor
por: Drzewiecka, Małgorzata, et al.
Publicado: (2023)

HDAC2 Inhibitor Valproic Acid Increases Radiation Sensitivity of Drug-Resistant Melanoma Cells
por: Kalal, Bhuvanesh Sukhlal, et al.
Publicado: (2019)

Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents
por: Fredly, Hanne, et al.
Publicado: (2013)

HDAC inhibitor valproic acid protects heart function through Foxm1 pathway after acute myocardial infarction
por: Tian, Shuo, et al.
Publicado: (2018)

Influence of the HDAC Inhibitor Valproic Acid on the Growth and Proliferation of Temsirolimus-Resistant Prostate Cancer Cells In Vitro
por: Makarević, Jasmina, et al.
Publicado: (2019)

HDAC (Histone Deacetylase) Inhibitor Valproic Acid Attenuates Atrial Remodeling and Delays the Onset of Atrial Fibrillation in Mice
por: Scholz, Beatrix, et al.
Publicado: (2019)

Valproic Acid as a Potential Inhibitor of Plasmodium falciparum Histone Deacetylase 1 (PfHDAC1): An in Silico Approach
por: Elbadawi, Mohamed A. Abdallah, et al.
Publicado: (2015)

The Class I HDAC Inhibitor Valproic Acid Strongly Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Immune System Activation
por: Blaauboer, Amber, et al.
Publicado: (2022)

Exposure to valproic acid (VPA) reproduces hdac1 loss of function phenotypes in zebrafish
por: Jones, Alec A., et al.
Publicado: (2023)

The histone deacetylase inhibitor valproic acid inhibits NKG2D expression in natural killer cells through suppression of STAT3 and HDAC3
por: Ni, Lulu, et al.
Publicado: (2017)

Resistance after Chronic Application of the HDAC-Inhibitor Valproic Acid Is Associated with Elevated Akt Activation in Renal Cell Carcinoma In Vivo
por: Juengel, Eva, et al.
Publicado: (2013)

In Vivo Screening Using Transgenic Zebrafish Embryos Reveals New Effects of HDAC Inhibitors Trichostatin A and Valproic Acid on Organogenesis
por: Li, Ling, et al.
Publicado: (2016)

Valproic Acid Inhibits Progressive Hereditary Hearing Loss in a KCNQ4 Variant Model through HDAC1 Suppression
por: Nam, Yoon Seok, et al.
Publicado: (2023)

HDAC Inhibition by Valproic Acid Induces Neuroprotection and Improvement of PD-like Behaviors in LRRK2 R1441G Transgenic Mice
por: Kim, Taewoo, et al.
Publicado: (2019)

Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish Xenografts
por: Wrobel, Jagoda K, et al.
Publicado: (2020)

Valproic Acid Inhibits Glioma and Its Mechanisms
por: Yang, Zhao-Yu, et al.
Publicado: (2022)

Histone Deacetylase Inhibition with Valproic Acid Downregulates Osteocalcin Gene Expression in Human Dental Pulp Stem Cells and Osteoblasts: Evidence for HDAC2 Involvement
por: Paino, Francesca, et al.
Publicado: (2014)

Cell type-specific anti-cancer properties of valproic acid: independent effects on HDAC activity and Erk1/2 phosphorylation
por: Gotfryd, Kamil, et al.
Publicado: (2010)

Valproic Acid Neuroprotection in the 6-OHDA Model of Parkinson's Disease Is Possibly Related to Its Anti-Inflammatory and HDAC Inhibitory Properties
por: Ximenes, José Christian Machado, et al.
Publicado: (2015)

Effects of the Histone Deacetylase Inhibitor Valproic Acid on Human Pericytes In Vitro
por: Karén, Jakob, et al.
Publicado: (2011)

Effects of histone deacetylase inhibitor valproic acid on skeletal myocyte development
por: Li, Qiao, et al.
Publicado: (2014)

Tumor Growth Mitigating Effects of Valproic Acid in Systemic Malignancies
por: Kapoor, Shailendra
Publicado: (2015)

Angioedema induced by valproic acid
por: Yildiz, Sevler, et al.
Publicado: (2021)

Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia – identification of responders by gene expression profiling of pretreatment leukemic cells
por: Reikvam, Håkon, et al.
Publicado: (2017)

HDAC Inhibition to Prime Immune Checkpoint Inhibitors
por: Borcoman, Edith, et al.
Publicado: (2021)

Disruption of Planar Cell Polarity Pathway Attributable to Valproic Acid-Induced Congenital Heart Disease through Hdac3 Participation in Mice
por: Duan, Hong-Yu, et al.
Publicado: (2018)

Inhibition of Valproic Acid-Induced Prenatal Developmental Abnormalities with Antioxidants in Rats
por: Saeed, Mamoona, et al.
Publicado: (2020)

Valproic Acid-Induced CCN1 Promotes Osteogenic Differentiation by Increasing CCN1 Protein Stability through HDAC1 Inhibition in Tonsil-Derived Mesenchymal Stem Cells
por: Yu, Yeonsil, et al.
Publicado: (2022)

Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines
por: Sixto-López, Yudibeth, et al.
Publicado: (2020)

Exquisite Tumor Targeting by Salmonella A1-R in Combination with Caffeine and Valproic Acid Regresses an Adult Pleomorphic Rhabdomyosarcoma Patient-Derived Orthotopic Xenograft Mouse Model
por: Igarashi, Kentaro, et al.
Publicado: (2019)

HDAC4 degradation by combined TRAIL and valproic acid treatment induces apoptotic cell death of TRAIL-resistant head and neck cancer cells
por: Lee, Bok-Soon, et al.
Publicado: (2018)

Valproic acid-induced abnormal behavior
por: Nagalakshmi, Nanjangud Chandrashekar, et al.
Publicado: (2010)

Assessing hepatotoxicity of valproic acid in Dictyostelium
Publicado: (2012)

Hyperammonemia Associated with Valproic Acid Concentrations
por: Vázquez, Marta, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7utkv9ph5c86sv06tddhv267vm